Searched for
GENERIC DRUG USER FEE AMENDMENTS
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...- WazirX bets on AI, futures trading to fuel comeback after $235-million hackCryptocurrency exchange WazirX is introducing AI-powered trading tools, advanced trading products and customer experience upgrades followin...
- Aadhaar email update to be free via mobile app from July 1; UIDAI waives Rs 75 fee for six monthsThe Unique Identification Authority of India (UIDAI) is making email address updates via the Aadhaar mobile app free for six months, from J...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- PhonePe wallet inactivity fees do not affect bank accounts or UPI transactionsPhonePe clarifies inactivity fees apply solely to its prepaid wallet, not linked bank accounts or UPI transactions. Users receiving notific...
- PPL India gets statutory backing for licensing sound recording rightsPhonographic Performance (PPL India), representing over 500 music labels, has officially received registration as a copyright society under...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- PhonePe wallet inactive? You will now be fined for not using itPhonePe is now charging a Rs 100 quarterly fee for inactive wallets. This fee applies if users have not made any financial transactions thr...
- Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soonIndian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federa...
- US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisitionThe U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a cond...
- Indian crypto traders are moving to futures. Here's where the math actually worksWazirX Futures brings direct INR access, the lowest fees in the domestic market, and built-in risk guardrails to a segment that has quietly...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Centre mandates prescription for syrup-based medicinesChemists must now have a doctor's prescription to sell cough syrups. The government has changed the Drugs Rules, 1945. This stops over-the-...
- Govt ends over-the-counter sales of all 'syrups'; mandates doctor's prescription for purchaseThe Union Ministry of Health and Family Welfare has mandated that all syrups, including cough syrups, are now prescription-only. This new r...
- Florida sues TikTok, claiming it violates state child safety lawThe lawsuit seeks a court order directing the platform, which is owned by ByteDance, to make changes to bring it into compliance with the l...
- Assam brings in MGR for liquor licences; prices likely to rise from July 1Assam's excise laws have been amended. A new provision, Minimum Guaranteed Revenue, will be introduced for liquor license holders. This wil...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
Load More
